Release Date: 28/04/17 17:08 Summary: Quarterly Activities Report and Quarterly Cashflow Report Price Sensitive: Yes Download Document 1.7MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%